Income Statement NetEase, Inc. Nasdaq

Stocks

NTES

US64110W1027

Internet Services

Market Closed - Nasdaq Other stock markets 04:00:00 16/07/2026 HKT			After hours 07:13:16
129.76 ^USD	+1.07%		131.10	+1.04%

07-15	China's DeepSeek to raise fresh capital at $74 billion valuation ahead of onshore IPO, sources say	RE
07-14	Asian Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading	MT

93fc6ef7b00c1228d9b526f60.mEz5qKgy19hmeeZVXMfFhzphAJ68mM7-DK7lx1Wz1OY.932ekMpHkO8-KJceP5eS0UBVS_ff87eYVZmHqTeK5o75Fp3bzmO2rl400g

Published financial data: NETEASE, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	87.61B	96.5B	103B	105B	113B
Total Revenues	87.61B	96.5B	103B	105B	113B
Cost of Goods Sold, Total	40.64B	43.73B	40.4B	39.49B	40.22B
Gross Profit	46.97B	52.77B	63.06B	65.81B	72.4B
Selling General & Admin Expenses, Total	16.48B	18.1B	18.87B	18.7B	18.85B
R&D Expenses	14.08B	15.04B	16.48B	17.52B	17.72B
Other Operating Expenses, Total	30.55B	33.14B	35.35B	36.22B	36.57B
Operating Income	16.42B	19.63B	27.71B	29.58B	35.83B
Interest Expense, Total	-191M	-650M	-884M	-598M	-334M
Interest And Investment Income	4.66B	2.85B	6.31B	5.87B	5.02B
Net Interest Expenses	4.47B	2.2B	5.43B	5.28B	4.68B
Currency Exchange Gains (Loss)	-490M	1.57B	-133M	255M	-776M
Other Non Operating Income (Expenses)	710M	847M	1.05B	602M	1.09B
EBT, Excl. Unusual Items	21.1B	24.25B	34.06B	35.72B	40.83B
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Gain (Loss) On Sale Of Assets	-	-	-	-	-
EBT, Incl. Unusual Items	21.1B	24.25B	34.06B	35.72B	40.83B
Income Tax Expense	4.13B	5.03B	4.7B	5.46B	6.03B
Earnings From Continuing Operations	16.98B	19.22B	29.36B	30.26B	34.8B
Earnings Of Discontinued Operations	-	625M	-	-	-
Net Income to Company	16.98B	19.84B	29.36B	30.26B	34.8B
Minority Interest	-119M	494M	59.33M	-559M	-1.04B
Net Income - (IS)	16.86B	20.34B	29.42B	29.7B	33.76B
Net Income to Common Incl Extra Items	16.86B	20.34B	29.42B	29.7B	33.76B
Net Income to Common Excl. Extra Items	16.86B	19.71B	29.42B	29.7B	33.76B
Per Share Items
Net EPS - Basic	5.07	6.23	9.15	9.28	10.59
Basic EPS - Continuing Operations	5.07	6.04	9.15	9.28	10.59
Basic Weighted Average Shares Outstanding	3.33B	3.26B	3.22B	3.2B	3.19B
Net EPS - Diluted	5.01	6.17	9.05	9.19	10.48
Diluted EPS - Continuing Operations	5.01	5.98	9.05	9.19	10.48
Diluted Weighted Average Shares Outstanding	3.37B	3.3B	3.25B	3.23B	3.22B
Normalized Basic EPS	3.93	4.8	6.64	6.8	7.68
Normalized Diluted EPS	3.88	4.75	6.56	6.74	7.61
Dividend Per Share	1.49	1.91	3.64	3.77	4.16
Payout Ratio	20.81	33.06	27.24	37.6	40.95
American Depositary Receipts Ratio (ADR)	5	5	5	5	5
Supplemental Items
EBITDA	19.69B	22.49B	30.76B	32B	38.08B
EBITA	16.5B	19.72B	27.81B	29.7B	35.96B
EBIT	16.42B	19.63B	27.71B	29.58B	35.83B
EBITDAR	20.27B	23.02B	31.11B	32.25B	38.25B
Total Revenues (As Reported)	-	-	-	-	-
Effective Tax Rate - (Ratio)	19.56	20.75	13.8	15.29	14.77
Current Domestic Taxes	-	-	-	-	-
Total Current Taxes	3.72B	4.54B	4.57B	5.14B	7.29B
Deferred Domestic Taxes	-	-	-	-	-
Total Deferred Taxes	408M	490M	131M	321M	-1.25B
Normalized Net Income	13.07B	15.65B	21.34B	21.76B	24.48B
Supplemental Operating Expense Items
Advertising Expense	3.76B	5.2B	-	-	-
Selling and Marketing Expenses	12.21B	13.4B	13.97B	14.15B	14.62B
General and Administrative Expenses	4.26B	4.7B	4.9B	4.55B	4.23B
Research And Development Expense From Footnotes	14.08B	15.04B	16.48B	17.52B	17.72B
Net Rental Expense, Total	580M	528M	345M	249M	169M
Imputed Operating Lease Interest Expense	42.29M	110M	99.59M	71.59M	46.15M
Imputed Operating Lease Depreciation	538M	419M	245M	178M	122M
Stock-Based Comp., COGS (Total)	833M	758M	824M	1.19B	1B
Stock-Based Comp., R&D Exp. (Total)	984M	1.08B	1.17B	1.52B	1.59B
Stock-Based Comp., S&M Exp. (Total)	119M	120M	133M	105M	133M
Stock-Based Comp., G&A Exp. (Total)	1.11B	1.21B	1.12B	1.07B	917M
Total Stock-Based Compensation	3.04B	3.17B	3.24B	3.88B	3.65B

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	14.5B	24.89B	21.43B	51.38B	47.17B
Short Term Investments	83.12B	92.64B	105B	86.29B	117B
Total Cash And Short Term Investments	97.62B	118B	127B	138B	164B
Accounts Receivable, Total	5.51B	5B	6.42B	5.67B	5.34B
Other Receivables	1.51B	1.41B	2.78B	2.46B	1.77B
Notes Receivable	41.84M	43.31M	45.57M	25.3M	86.56M
Total Receivables	7.06B	6.46B	9.25B	8.16B	7.2B
Inventory	965M	994M	695M	572M	689M
Prepaid Expenses	3.95B	3.01B	2.95B	3.61B	3.92B
Deferred Tax Assets Current	-	-	-	-	-
Restricted Cash	2.88B	2.7B	2.78B	3.09B	4.32B
Other Current Assets, Total	649M	919M	216M	224M	247M
Total Current Assets	113B	132B	143B	153B	181B
Gross Property Plant And Equipment	11.76B	13.5B	15.75B	16.24B	16.42B
Accumulated Depreciation	-5.28B	-6.27B	-6.92B	-7.18B	-7.68B
Net Property Plant And Equipment	6.48B	7.23B	8.82B	9.06B	8.75B
Long-term Investments	24.63B	21.52B	22.83B	23.23B	21.46B
Goodwill	595M	2.17B	1.86B	1.86B	1.86B
Other Intangibles, Total	6.73B	6.24B	5.96B	5.59B	4.99B
Loans Receivable Long-Term	55.28M	39.23M	34.69M	17.05M	16.06M
Deferred Tax Assets Long-Term	1.3B	1.48B	1.56B	1.11B	2.83B
Other Long-Term Assets, Total	743M	2.48B	2.16B	1.8B	898M
Total Assets	154B	173B	186B	196B	221B
Liabilities
Accounts Payable, Total	985M	1.51B	881M	721M	643M
Accrued Expenses, Total	9B	10.23B	11.28B	12.05B	12.33B
Short-term Borrowings	19.35B	23.88B	19.24B	11.81B	6.38B
Current Portion of Leases	334M	259M	259M	172M	113M
Current Income Taxes Payable	3.46B	2.12B	1.79B	1.74B	2.79B
Unearned Revenue Current, Total	12.31B	12.7B	13.72B	15.76B	20.98B
Deferred Tax Liability Current	-	-	-	-	-
Other Current Liabilities	5.06B	6.14B	6.68B	7.42B	9.13B
Total Current Liabilities	50.5B	56.83B	53.84B	49.67B	52.37B
Long-Term Debt	1.28B	3.65B	428M	428M	-
Long-Term Leases	732M	673M	556M	413M	232M
Deferred Tax Liability Non Current	1.35B	2.13B	2.3B	2.17B	2.64B
Other Non Current Liabilities	366M	605M	715M	816M	1.07B
Total Liabilities	54.22B	63.89B	57.84B	53.5B	56.31B
Common Stock, Total	2.79M	2.71M	2.71M	2.63M	2.63M
Additional Paid In Capital	37.92B	22.85B	22.6B	9.86B	9.84B
Retained Earnings	78.74B	92.35B	114B	132B	152B
Treasury Stock	-20.5B	-10.91B	-12.69B	-4.47B	-1.52B
Comprehensive Income and Other	-828M	432M	617M	1.01B	-238M
Total Common Equity	95.33B	105B	124B	139B	160B
Minority Interest	4.1B	4.14B	3.8B	3.81B	4.81B
Total Equity	99.42B	109B	128B	142B	165B
Total Liabilities And Equity	154B	173B	186B	196B	221B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	3.1B	3.13B	3.21B	3.17B	3.19B
ECS Total Common Shares Outstanding	3.1B	3.13B	3.21B	3.17B	3.19B
Book Value / Share	30.74	33.5	38.71	43.78	50.22
Tangible Book Value	88.01B	96.33B	116B	131B	153B
Tangible Book Value Per Share	28.38	30.81	36.27	41.43	48.07
Total Debt	21.69B	28.46B	20.48B	12.82B	6.73B
Net Debt	-75.93B	-89.07B	-106B	-125B	-158B
Debt Equivalent Oper. Leases	4.64B	4.23B	2.76B	1.99B	1.35B
Minority Interest, Total (Incl. Fin. Div)	4.1B	4.14B	3.8B	3.81B	4.81B
Equity Method Investments, Total	3.78B	5.24B	6.11B	6.41B	4.52B
Account Code - Inventory Valuation	6	6	6	6	6
Buildings, Total	3.68B	3.88B	4.06B	6.89B	7.91B
Machinery, Total	5.86B	6.5B	6.76B	6.75B	6.75B
Full Time Employees	32.06K	31.12K	29.13K	26.03K	25.38K
Part Time Employees	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	370M	403M	449M	689M	1.03B

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	16.86B	20.34B	29.42B	29.7B	33.76B
Depreciation & Amortization - CF	3.19B	2.77B	2.95B	2.31B	2.12B
Amortization of Goodwill and Intangible Assets - (CF)	87.4M	91.8M	102M	113M	126M
Depreciation & Amortization, Total	3.28B	2.86B	3.06B	2.42B	2.25B
(Gain) Loss From Sale Of Asset	54.05M	3.62M	5.68M	-4.76M	-30.29M
(Gain) Loss on Sale of Investments - (CF)	-1.2B	1.27B	-544M	-353M	15.7M
(Income) Loss On Equity Investments - (CF)	-1.57B	-1.26B	-474M	156M	1.54B
Stock-Based Compensation (CF)	3.04B	3.17B	3.24B	3.88B	3.65B
Provision and Write-off of Bad Debts	266M	61.39M	61.15M	68.93M	368M
Net Cash From Discontinued Operations	-	-625M	-	-	-
Other Operating Activities, Total	1.02B	-1.61B	192M	160M	473M
Change In Accounts Receivable	-1.19B	554M	-1.47B	716M	264M
Change In Inventories	-344M	-27.61M	297M	124M	-118M
Change In Accounts Payable	-155M	448M	-559M	91.14M	-71.62M
Change in Unearned Revenues	1.35B	385M	1.16B	2.02B	5.44B
Change In Income Taxes	255M	-918M	-244M	188M	1.11B
Change in Other Net Operating Assets	3.27B	3.06B	1.19B	510M	2.1B
Cash from Operations	24.93B	27.71B	35.33B	39.68B	50.74B
Capital Expenditure	-1.6B	-2.1B	-2.3B	-1.28B	-1.07B
Sale of Property, Plant, and Equipment	71.52M	41.47M	10.3M	14.53M	45.89M
Divestitures	-	-	-	-	-
Sale (Purchase) of Intangible assets	-1.51B	-543M	-1.97B	-931M	-987M
Investment in Marketable and Equity Securities, Total	-3.77B	-4.44B	-12.35B	20.51B	-31.21B
Other Investing Activities, Total	-269M	-324M	-424M	-407M	39.64M
Cash from Investing	-7.08B	-7.37B	-17.04B	17.92B	-33.18B
Short Term Debt Issued, Total	4.45B	-	-	-	244M
Long-Term Debt Issued, Total	-	6.39B	13.57B	13.92B	5.55B
Total Debt Issued	4.45B	6.39B	13.57B	13.92B	5.8B
Short Term Debt Repaid, Total	-2.74B	-1.27B	-13.65B	-6.66B	-
Long-Term Debt Repaid, Total	-	-274M	-8.22B	-14.74B	-11.6B
Total Debt Repaid	-2.74B	-1.55B	-21.87B	-21.4B	-11.6B
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-12.91B	-8.33B	-5.23B	-8.83B	-639M
Common Dividends Paid	-3.51B	-6.72B	-8.01B	-11.17B	-13.83B
Common & Preferred Stock Dividends Paid	-3.51B	-6.72B	-8.01B	-11.17B	-13.83B
Other Financing Activities, Total	2.13B	-30.92M	86.16M	136M	104M
Cash from Financing	-12.59B	-10.24B	-21.47B	-27.34B	-20.16B
Foreign Exchange Rate Adjustments	-55.35M	110M	-202M	10.75M	-382M
Net Change in Cash	5.21B	10.21B	-3.38B	30.27B	-2.98B
Supplemental Items
Cash Interest Paid	188M	588M	780M	490M	388M
Cash Income Tax Paid (Refund)	3.55B	5.09B	4.9B	5.19B	6.43B
Levered Free Cash Flow	16.05B	18.55B	18.62B	25.8B	33.49B
Unlevered Free Cash Flow	16.17B	18.96B	19.17B	26.17B	33.7B
Change In Net Working Capital	-2.71B	-3.3B	166M	-3.59B	-7.46B
Net Debt Issued / Repaid	1.71B	4.85B	-8.31B	-7.48B	-5.8B

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	6.94	7.52	9.66	9.68	10.73
Return on Total Capital	8.72	9.49	12.11	12.17	13.69
Return On Equity %	17.57	18.45	24.78	22.36	22.63
Return on Common Equity	19	19.71	25.69	22.59	22.58
Margin Analysis
Gross Profit Margin %	53.62	54.68	60.95	62.5	64.29
SG&A Margin	18.81	18.76	18.24	17.76	16.73
EBITDA Margin %	22.48	23.3	29.73	30.39	33.81
EBITA Margin %	18.84	20.44	26.88	28.2	31.93
EBIT Margin %	18.74	20.34	26.78	28.1	31.82
Income From Continuing Operations Margin %	19.38	19.92	28.37	28.73	30.9
Net Income Margin %	19.24	21.08	28.43	28.2	29.98
Net Avail. For Common Margin %	19.24	20.43	28.43	28.2	29.98
Normalized Net Income Margin	14.92	16.22	20.63	20.67	21.74
Levered Free Cash Flow Margin	18.33	19.23	18	24.5	29.73
Unlevered Free Cash Flow Margin	18.46	19.65	18.53	24.85	29.92
Asset Turnover
Asset Turnover	0.59	0.59	0.58	0.55	0.54
Fixed Assets Turnover	14.85	14.08	12.89	11.77	12.65
Receivables Turnover (Average Receivables)	17.37	18.36	18.11	17.42	20.46
Inventory Turnover (Average Inventory)	52.22	44.66	47.84	62.34	63.81
Short Term Liquidity
Current Ratio	2.24	2.32	2.65	3.09	3.45
Quick Ratio	2.07	2.18	2.53	2.94	3.27
Operating Cash Flow to Current Liabilities	0.49	0.49	0.66	0.8	0.97
Days Sales Outstanding (Average Receivables)	21.01	19.88	20.15	21.01	17.84
Days Outstanding Inventory (Average Inventory)	6.99	8.17	7.63	5.87	5.72
Average Days Payable Outstanding	9.43	10.39	10.87	7.45	6.17
Cash Conversion Cycle (Average Days)	18.56	17.66	16.91	19.44	17.39
Long Term Solvency
Total Debt/Equity	21.82	26.14	15.99	8.99	4.08
Total Debt / Total Capital	17.91	20.72	13.79	8.25	3.92
LT Debt/Equity	2.02	3.97	0.77	0.59	0.14
Long-Term Debt / Total Capital	1.66	3.15	0.66	0.54	0.14
Total Liabilities / Total Assets	35.29	36.98	31.11	27.3	25.43
EBIT / Interest Expense	85.82	30.19	31.34	49.47	107.16
EBITDA / Interest Expense	105.98	35.4	35.19	53.93	114.39
(EBITDA - Capex) / Interest Expense	97.6	32.17	32.58	51.8	111.2
Total Debt / EBITDA	1.07	1.24	0.66	0.4	0.18
Net Debt / EBITDA	-3.75	-3.87	-3.42	-3.87	-4.12
Total Debt / (EBITDA - Capex)	1.16	1.36	0.71	0.41	0.18
Net Debt / (EBITDA - Capex)	-4.07	-4.26	-3.69	-4.03	-4.24
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	18.92	10.15	7.23	1.77	6.96
Gross Profit, 1 Yr. Growth %	20.49	12.34	19.51	4.35	10.02
EBITDA, 1 Yr. Growth %	9.43	14.19	36.81	4.02	19
EBITA, 1 Yr. Growth %	12.87	19.49	41.03	6.78	21.09
EBIT, 1 Yr. Growth %	12.92	19.56	41.17	6.77	21.13
Earnings From Cont. Operations, 1 Yr. Growth %	37.68	13.21	52.76	3.06	15.01
Net Income, 1 Yr. Growth %	39.74	20.65	44.64	0.96	13.68
Normalized Net Income, 1 Yr. Growth %	39.94	19.74	36.38	1.97	12.48
Diluted EPS Before Extra, 1 Yr. Growth %	39.17	19.36	51.34	1.55	14.08
Accounts Receivable, 1 Yr. Growth %	20.36	-9.17	28.37	-11.73	-5.84
Inventory, 1 Yr. Growth %	63.1	3	-30.02	-17.81	20.58
Net Property, Plant and Equip., 1 Yr. Growth %	21.7	11.61	22.05	2.68	-3.48
Total Assets, 1 Yr. Growth %	8.3	12.44	7.62	5.41	12.97
Tangible Book Value, 1 Yr. Growth %	19.73	9.45	20.91	12.68	16.92
Common Equity, 1 Yr. Growth %	16.07	9.86	18.67	11.59	15.58
Cash From Operations, 1 Yr. Growth %	0.15	11.16	27.51	12.3	27.88
Capital Expenditures, 1 Yr. Growth %	51.75	31.12	9.58	-44.59	-16.47
Levered Free Cash Flow, 1 Yr. Growth %	-0.87	15.56	0.37	38.52	29.82
Unlevered Free Cash Flow, 1 Yr. Growth %	-1.08	17.22	1.13	36.48	28.76
Dividend Per Share, 1 Yr. Growth %	45.21	28.71	90.11	3.75	10.27
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	21.61	14.45	8.68	4.46	4.33
Gross Profit, 2 Yr. CAGR %	22	16.34	15.87	11.68	7.15
EBITDA, 2 Yr. CAGR %	9.57	11.78	24.99	19.3	11.26
EBITA, 2 Yr. CAGR %	9.11	16.13	29.81	22.71	13.71
EBIT, 2 Yr. CAGR %	9.11	16.19	29.92	22.77	13.72
Earnings From Cont. Operations, 2 Yr. CAGR %	12.27	24.85	31.5	25.47	8.87
Net Income, 2 Yr. CAGR %	-10.91	29.85	32.1	20.84	7.13
Normalized Net Income, 2 Yr. CAGR %	14.07	29.45	27.79	17.93	7.09
Diluted EPS Before Extra, 2 Yr. CAGR %	10.81	28.88	34.4	23.97	7.63
Accounts Receivable, 2 Yr. CAGR %	14.94	4.56	7.98	6.45	-8.83
Inventory, 2 Yr. CAGR %	21.78	29.61	-15.1	-24.16	-0.45
Net Property, Plant and Equip., 2 Yr. CAGR %	12.86	16.55	16.71	11.95	-0.45
Total Assets, 2 Yr. CAGR %	17.06	10.35	10	6.51	9.13
Tangible Book Value, 2 Yr. CAGR %	27.54	14.48	15.04	16.73	14.78
Common Equity, 2 Yr. CAGR %	24.55	12.93	14.18	15.07	13.57
Cash From Operations, 2 Yr. CAGR %	20.33	5.52	19.05	19.66	19.84
Capital Expenditures, 2 Yr. CAGR %	15.08	41.06	19.87	-22.07	-31.96
Levered Free Cash Flow, 2 Yr. CAGR %	-0.11	6.52	7.3	16.64	32.15
Unlevered Free Cash Flow, 2 Yr. CAGR %	0.26	7.68	8.88	17.49	32.56
Dividend Per Share, 2 Yr. CAGR %	-11.99	36.71	56.43	40.45	6.96
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	19.62	17.66	11.99	6.32	5.29
Gross Profit, 3 Yr. CAGR %	19.76	18.69	17.39	11.9	11.12
EBITDA, 3 Yr. CAGR %	17.83	11.08	19.57	17.57	19.2
EBITA, 3 Yr. CAGR %	18.14	12.47	23.9	21.63	22.17
EBIT, 3 Yr. CAGR %	18.06	12.49	23.98	21.69	22.22
Earnings From Cont. Operations, 3 Yr. CAGR %	25.37	12.58	33.53	21.24	21.88
Net Income, 3 Yr. CAGR %	39.93	-1.43	34.6	20.78	18.4
Normalized Net Income, 3 Yr. CAGR %	25.5	15.93	31.72	18.53	16.08
Diluted EPS Before Extra, 3 Yr. CAGR %	25.25	13.59	35.97	22.41	20.58
Accounts Receivable, 3 Yr. CAGR %	11.23	6.26	11.96	0.97	2.18
Inventory, 3 Yr. CAGR %	-3.26	15.16	5.54	-16.01	-11.48
Net Property, Plant and Equip., 3 Yr. CAGR %	11.51	12.45	18.35	11.84	6.55
Total Assets, 3 Yr. CAGR %	20.89	15.5	9.43	8.45	8.62
Tangible Book Value, 3 Yr. CAGR %	30.61	21.2	16.58	14.25	16.79
Common Equity, 3 Yr. CAGR %	28.21	19.45	14.81	13.31	15.24
Cash From Operations, 3 Yr. CAGR %	22.94	17.19	12.39	16.76	22.34
Capital Expenditures, 3 Yr. CAGR %	-9.62	20.2	29.67	-7.31	-20.25
Levered Free Cash Flow, 3 Yr. CAGR %	26.68	4.86	4.43	16.84	20.88
Unlevered Free Cash Flow, 3 Yr. CAGR %	26.99	5.62	5.46	17.4	21.13
Dividend Per Share, 3 Yr. CAGR %	45.07	-0.1	52.6	36.42	29.57
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	18.07	16.78	15.12	12.19	8.86
Gross Profit, 5 Yr. CAGR %	16.74	16.07	18.19	15.84	13.18
EBITDA, 5 Yr. CAGR %	8.73	10.28	20.64	14.3	16.17
EBITA, 5 Yr. CAGR %	5.48	8.68	22.68	16.46	19.72
EBIT, 5 Yr. CAGR %	5.39	8.6	22.67	16.49	19.77
Earnings From Cont. Operations, 5 Yr. CAGR %	7.56	10.47	27.79	17.57	23.06
Net Income, 5 Yr. CAGR %	7.75	13.69	36.74	6.94	22.85
Normalized Net Income, 5 Yr. CAGR %	9	12.96	26.41	16.72	21.25
Diluted EPS Before Extra, 5 Yr. CAGR %	7.38	11.44	28.83	17.63	23.84
Accounts Receivable, 5 Yr. CAGR %	5.32	6.69	9.92	6.34	3.13
Inventory, 5 Yr. CAGR %	-9.37	-28.92	-8.18	-2.56	3.1
Net Property, Plant and Equip., 5 Yr. CAGR %	21.77	13.91	13.56	12.25	10.44
Total Assets, 5 Yr. CAGR %	21.5	19.45	16.41	11.82	9.31
Tangible Book Value, 5 Yr. CAGR %	18.7	16.8	24.14	19.39	15.86
Common Equity, 5 Yr. CAGR %	20.07	18.02	22.4	17.68	14.31
Cash From Operations, 5 Yr. CAGR %	9.98	18.44	21.37	18.17	15.31
Capital Expenditures, 5 Yr. CAGR %	7.12	4.89	1.19	1.07	0.19
Levered Free Cash Flow, 5 Yr. CAGR %	10.18	33.61	18.72	9.9	15.42
Unlevered Free Cash Flow, 5 Yr. CAGR %	10.34	34.19	19.41	10.22	15.56
Dividend Per Share, 5 Yr. CAGR %	10.16	19.55	49.51	14.48	32.38